Strumento inattivo

Altre lingue Telferscot Resources Inc Canadian Securities Exchange

Azioni

TFS

CA87957T1066

Prezzo di chiusura Canadian Securities Exchange Altri mercati azionari
-	-

2023	Canntab Therapeutics Limited fornisce un aggiornamento sulla consegna del prodotto	CI
2023	Canntab Therapeutics Limited riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 28 febbraio 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding	15/04
Canadian Investment Regulatory Organization Trading Halt - PILL	05/10/23
Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order	18/09/23
Canntab Therapeutics Limited Provide an Update on Product Delivery	22/08/23
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	22/08/23
Canntab Therapeutics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023	27/04/23
Canntab Therapeutics Limited Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022	26/01/23
IIROC Trade Resumption - PILL	22/11/22
IIROC Trading Halt - PILL	21/11/22
Canntab Therapeutics Limited Reports Earnings Results for the First Quarter Ended August 31, 2022	28/10/22
Canntab Therapeutics Limited Auditor Raises 'Going Concern' Doubt	28/09/22
Canntab Therapeutics Limited Reports Earnings Results for the Full Year Ended May 31, 2022	28/09/22
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	23/08/22
Canntab Therapeutics on Entrance Into the Nova Scotia Cannabis Market	22/08/22
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET	22/08/22
Canntab Therapeutics Limited Announces Chief Executive Office Changes	02/08/22
CANNTAB ANNOUNCES CHANGE OF AUDITOR	30/05/22
Canntab Therapeutics : 2022Feb28 Q3 Interim MD&A	30/04/22
Canntab Therapeutics : 2022Feb28 q3 Interim FS	30/04/22
Canntab Therapeutics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	29/04/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Telferscot Resources Inc Canadian Securities Exchange

Azioni

TFS

CA87957T1066

Altre lingue

Filtri